Antitumor Cream: Transdermal Hydrogel Containing Liposome‐Encapsulated Ruthenium Complex for Infrared‐Controlled Multimodal Synergistic Therapy
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202403563 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Yu-Fei Yan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education, School of Pharmacy, Yunnan University, East Outer Ring Road, Kunmi…. Hauptthemen laut MEDLINE: Liposomes, Ruthenium, Hydrogels, Antineoplastic Agents. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 91 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Yunnan Provincial Science and Technology Department, Ten Thousand Talent Plans for Young Top-notch Talents of Yunnan Province.
Abstract (Originalsprache)
A transdermal drug delivery cream, which is non‐invasive and painless, containing a liposome‐encapsulated Ru(II) complex ( LipoRu ) is created for the treatment of skin cancer. This formulation capitalizes on the synergistic antitumor effects of two‐photon excited photodynamic therapy (PDT), photothermal therapy (PTT), and chemotherapy. LipoRu exhibits effective tumor accumulation, efficient cellular uptake, pH‐sensitive and infrared‐accelerated release, and dual localization to the nucleus and mitochondria. The released Ru(II) complexes within cells exert multiple antitumor mechanisms, such as DNA topoisomerase and RNA polymerase inhibition, Type I and II PDT, PTT, DNA photodamage, and apoptosis and ferroptosis induction. The biodistribution and therapeutic efficacy of LipoRu in vivo are systematically compared via three distinct administration routes: intratumoral injection, intravenous injection, and transdermal delivery through topical cream application. The positive therapeutic effects of the LipoRu cream fabricated here in subcutaneous tumor‐bearing mice offer optimistic potential for the painless and non‐invasive treatment of both early‐stage and advanced skin cancers, as well as superficially located solid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education, School of Pharmacy, Yunnan University, East Outer Ring Road, Kunming, 650500, P. R. China.
- Animal Research and Resource Center, School of Life Sciences, Yunnan University, East Outer Ring Road, Kunming, 650500, P. R. China.
ORCID-Profile: Feng Gao
Förderung
- National Natural Science Foundation of China
- Yunnan Provincial Science and Technology Department
- Ten Thousand Talent Plans for Young Top-notch Talents of Yunnan Province
Zitieren
APA
Yan, Y. F., Li, X. L., Zeng, L. Z., Liu, Q., Cai, Z., Ren, Y., Ren, X., & Gao, F. (2025). Antitumor Cream: Transdermal Hydrogel Containing Liposome‐Encapsulated Ruthenium Complex for Infrared‐Controlled Multimodal Synergistic Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202403563
Vancouver
Yan YF, Li XL, Zeng LZ, Liu Q, Cai Z, Ren Y, et al. Antitumor Cream: Transdermal Hydrogel Containing Liposome‐Encapsulated Ruthenium Complex for Infrared‐Controlled Multimodal Synergistic Therapy. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202403563
BibTeX
@article{Yan2025,
author = {Yan, Yu-Fei and Li, Xue-Lian and Zeng, Li-Zhen and Liu, Qishuai and Cai, Zhongyan and Ren, Yanrong and Ren, Xiaoxia and Gao, Feng},
title = {Antitumor Cream: Transdermal Hydrogel Containing Liposome‐Encapsulated Ruthenium Complex for Infrared‐Controlled Multimodal Synergistic Therapy},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202403563}
}
EUVIMED